{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:45:14Z","timestamp":1790394314513,"version":"4.1.0"},"reference-count":134,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2112,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1111\/j.1755-5949.2009.00115.x","type":"journal-article","created":{"date-parts":[[2009,11,19]],"date-time":"2009-11-19T22:01:43Z","timestamp":1258668103000},"page":"237-249","source":"Crossref","is-referenced-by-count":121,"title":["TGF-\u03b21 Pathway as a New Target for Neuroprotection in Alzheimer's Disease"],"prefix":"10.1111","volume":"17","author":[{"given":"Filippo","family":"Caraci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Carbonaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Laura","family":"Giuffrida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Drago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Angela","family":"Sortino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Copani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,11,19]]},"reference":[{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/09540260802099968","article-title":"Neuropsychiatric symptoms in dementia: Importance and treatment considerations","volume":"20","author":"Ballard","year":"2008","journal-title":"Int Rev Psychiatry"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nm0706-780","article-title":"Alzheimer's disease: Progress or profit?","volume":"12","author":"Mount","year":"2006","journal-title":"Nature Med"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1093\/brain\/awl280","article-title":"Therapeutic approaches to Alzheimer's disease","volume":"129","author":"Klafki","year":"2006","journal-title":"Brain"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"17294","DOI":"10.1074\/jbc.M500997200","article-title":"Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers","volume":"280","author":"Demuro","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.freeradbiomed.2007.05.037","article-title":"Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment","volume":"43","author":"Butterfield","year":"2007","journal-title":"Free Radic Bio Med"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1523\/JNEUROSCI.12-02-00376.1992","article-title":"beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity","volume":"12","author":"Mattson","year":"1992","journal-title":"J Neurosci"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.neuint.2004.03.007","article-title":"Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease","volume":"45","author":"Hynd","year":"2004","journal-title":"Neurochem Int"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"19011","DOI":"10.1074\/jbc.274.27.19011","article-title":"Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F-DP, in \u03b2-amyloid-induced neuronal death","volume":"274","author":"Giovanni","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1096\/fasebj.13.15.2225","article-title":"Mitotic signaling by beta-amyloid causes neuronal death","volume":"13","author":"Copani","year":"1999","journal-title":"FASEB J"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1096\/fj.02-0422fje","article-title":"Erratic expression of DNA polymerases by beta-amyloid causes neuronal death","volume":"16","author":"Copani","year":"2002","journal-title":"FASEB J"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1523\/JNEUROSCI.3347-04.2004","article-title":"Divide and die: Cell cycle events as triggers of nerve cell death","volume":"24","author":"Herrup","year":"2004","journal-title":"J Neurosci"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"10949","DOI":"10.1523\/JNEUROSCI.2793-06.2006","article-title":"DNA polymerase-\u00df is early expressed in neurons of Alzheimer's Disease brain and is loaded into DNA replication forks in neurons challenged with \u00df-amyloid","volume":"26","author":"Copani","year":"2006","journal-title":"J Neurosci"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/JAD-2002-4508","article-title":"AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576","volume":"4","author":"Otth","year":"2002","journal-title":"J Alzheimers Dis"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0168-0102(98)00061-3","article-title":"Activation of tau protein kinase I\/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons","volume":"31","author":"Takashima","year":"1998","journal-title":"Neurosci Res"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/emboj\/20.1.27","article-title":"Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice","volume":"20","author":"Lucas","year":"2001","journal-title":"EMBO J"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0168-9525(01)02449-0","article-title":"Transgenic mouse models of Alzheimer's disease","volume":"17","author":"Hock","year":"2001","journal-title":"Trends Genet"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/nlme.2000.3991","article-title":"Hippocampal injections of amyloid beta-peptide 1-40 impair subsequent one-trial\/day reward learning","volume":"76","author":"Malin","year":"2001","journal-title":"Neurobiol Learn Mem"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s004010050825","article-title":"Beta-amyloid(1-40)-induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield","volume":"95","author":"Miguel-Hidalgo","year":"1998","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0306-4522(97)00507-1","article-title":"Co-injection of beta-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons","volume":"84","author":"Morimoto","year":"1998","journal-title":"Neuroscience"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0173(98)00004-6","article-title":"The role of neuronal growth factors in neurodegenerative disorders of the human brain","volume":"27","author":"Connor","year":"1998","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuron.2006.06.019","article-title":"Neurotrophins and dementia-keeping in touch","volume":"51","author":"Castren","year":"2006","journal-title":"Neuron"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/156720506777632916","article-title":"Tgf-Beta pathway as a potential target in neurodegeneration and Alzheimer's","volume":"3","author":"Wyss-Coray","year":"2006","journal-title":"Curr Alzh Res"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0896-6273(03)00766-9","article-title":"Loss of TGF-\u03b21 leads to increased neuronal cell death and microgliosis in mouse brain","volume":"40","author":"Brionne","year":"2003","journal-title":"Neuron"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.tibs.2004.03.008","article-title":"New insights into TGF-beta-Smad signalling","volume":"29","author":"Ten Dijke","year":"2004","journal-title":"Trends Biochem Sci"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0065-230X(08)60740-X","article-title":"Extracellular matrixassociated transforming growth factor-beta: Role in cancer cell growth and invasion","volume":"75","author":"Taipale","year":"1998","journal-title":"Adv Cancer Res"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev.immunol.24.021605.090737","article-title":"Transforming growth factor-\u03b2 regulation of immune responses","volume":"24","author":"Li","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"10618","DOI":"10.1074\/jbc.270.18.10618","article-title":"Processing of transforming growth factor beta 1 precursor by human furin convertase","volume":"270","author":"Dubois","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/jcp.1041210123","article-title":"Normal embryo fibroblasts release transforming growth factors in a latent form","volume":"121","author":"Lawrence","year":"1984","journal-title":"J Cell Physiol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1242\/jcs.00229","article-title":"Making sense of latent TGFbeta activation","volume":"116","author":"Annes","year":"2003","journal-title":"J Cell Sci"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-beta signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003","journal-title":"Cell"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-beta family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.phrs.2008.02.001","article-title":"TGF-beta1 targets the GSK-3beta\/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts","volume":"57","author":"Caraci","year":"2008","journal-title":"Pharmacol Res"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1083\/jcb.200407027","article-title":"TGF-{beta}1 activates two distinct type I receptors in neurons: Implications for neuronal NF-{kappa}B signaling","volume":"168","author":"K\u00f6nig","year":"2005","journal-title":"J Cell Biol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.nbd.2008.01.007","article-title":"TGF-beta 1 protects against Abeta-neurotoxicity via the phosphatidylinositol-3-kinase pathway","volume":"30","author":"Caraci","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cytogfr.2005.09.011","article-title":"Transforming growth factor-\u03b2 signalling in brain disorder","volume":"17","author":"Vivien","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/jcb.240530408","article-title":"TGF-\u03b21 is an organizer of response to neurodegeneration","volume":"53","author":"Finch","year":"1993","journal-title":"J Cell Biochem"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s00262-008-0639-6","article-title":"Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53","volume":"58","author":"Salvioli","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"Inflamm-aging. An evolutionary perspective on immunosenescence","volume":"908","author":"Franceschi","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1074\/jbc.M006809200","article-title":"Subcytotoxic H2O2 stress triggers a release of transforming growth factor-beta 1, which induces biomarkers of cellular senescence of human diploid fibroblasts","volume":"276","author":"Frippiat","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1474-9728.2004.00129.x","article-title":"The G\/C915 polymorphism of transforming growth factor beta1 is associated with human longevity: A study in Italian centenarians","volume":"3","author":"Carrieri","year":"2004","journal-title":"Aging Cell"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0047-6374(03)00025-3","article-title":"Plasma cytokine profiles in elderly humans","volume":"124","author":"Forsey","year":"2003","journal-title":"Mech Ageing Dev"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0197-4580(01)00285-8","article-title":"Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia","volume":"23","author":"Tarkowski","year":"2002","journal-title":"Neurobiol Aging"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1128\/CDLI.1.4.433-436.1994","article-title":"Serum cytokine levels in patients with Alzheimer's disease","volume":"1","author":"Chao","year":"1994","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.exger.2004.07.007","article-title":"Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease","volume":"39","author":"Mocali","year":"2004","journal-title":"Exp Gerontol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.mad.2007.07.006","article-title":"+10 T\/C polymorphisms in the gene of transforming growth factor-beta1 are associated with neurodegeneration and its clinical evolution","volume":"128","author":"Arosio","year":"2007","journal-title":"Mech Ageing Dev"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/jnr.21072","article-title":"Ectopic expression of phospho-Smad2 in Alzheimer's disease: Uncoupling of the transforming growth factor-beta pathway?","volume":"84","author":"Lee","year":"2006","journal-title":"J Neurosci Res"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1172\/JCI27341","article-title":"Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology","volume":"116","author":"Tesseur","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1111\/j.1460-9568.2006.05109.x","article-title":"Altered subcellular location of phosphorylated Smads in Alzheimer's disease","volume":"24","author":"Ueberham","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/nen.0b013e3180303b93","article-title":"Neurofibrillary tangles may interfere with Smad 2\/3 signaling in neurons","volume":"66","author":"Chalmers","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0006-291X(02)00725-8","article-title":"Transforming growth factor-beta-induced transcription of the Alzheimer beta-amyloid precursor protein gene involves interaction between the CTCFcomplex and Smads","volume":"295","author":"Burton","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"18408","DOI":"10.1074\/jbc.M300819200","article-title":"Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in transgenic mice","volume":"278","author":"Lesne","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/39321","article-title":"Amyloidogenic role of cytokine TGF-\u03b21 in transgenic mice and Alzheimer's disease","volume":"389","author":"Wyss-Coray","year":"1997","journal-title":"Nature"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nbd.2004.11.008","article-title":"Reduced brain tissue perfusion in TGF-beta 1 transgenic mice showing Alzheimer's disease-like cerebrovascular abnormalities","volume":"19","author":"Gaertner","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"10366","DOI":"10.1523\/JNEUROSCI.18-24-10366.1998","article-title":"Effects of transforming growth factor-beta (isoforms 1-3) on amyloid-beta deposition, inflammation, and cell targeting in organotypic hippocampal slice cultures","volume":"18","author":"Harris-White","year":"1998","journal-title":"J Neurosci"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0002-9440(10)61105-4","article-title":"Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer's disease brain","volume":"160","author":"Grammas","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nm1781","article-title":"Blocking TGF-beta-Smad2\/3 innate immune signaling mitigates Alzheimer-like pathology","volume":"14","author":"Town","year":"2008","journal-title":"Nat Med"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/87945","article-title":"TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice","volume":"7","author":"Wyss-Coray","year":"2001","journal-title":"Nat Med"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/archneur.57.8.1153","article-title":"Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia","volume":"57","author":"Luterman","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1074\/jbc.M409101200","article-title":"The amyloid-beta peptide suppresses transforming growth factor-beta1-induced matrix metalloproteinase-2 production via Smad7 expression in human monocytic THP-1 cells","volume":"280","author":"Lee","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bbadis.2006.12.005","article-title":"Linking cell-cycle dysfunction in Alzheimer's disease to a failure of synaptic plasticity","volume":"1772","author":"Arendt","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1083\/jcb.132.3.413","article-title":"Mitotic mechanisms in Alzheimer's disease?","volume":"132","author":"Vincent","year":"1996","journal-title":"J Cell Biol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1523\/JNEUROSCI.3347-04.2004","article-title":"Divide and die: Cell cycle events as triggers of nerve cell death","volume":"24","author":"Herrup","year":"2004","journal-title":"J Neurosci"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbadis.2006.10.016","article-title":"The nature of the cell cycle in neurons: Focus on a \u201cnon-canonical\u201d pathway of DNA replication causally related to death","volume":"1772","author":"Copani","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0301-0082(97)00066-X","article-title":"Transforming growth factor-\u03b2s in neurodegenerative disease","volume":"54","author":"Flanders","year":"1998","journal-title":"Prog Neurobiol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"43329","DOI":"10.1074\/jbc.M305835200","article-title":"Astrocyte protection of neurons: Role of transforming growth factor-beta signaling via a c-Jun-AP-1 protective pathway","volume":"278","author":"Dhandapani","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1210\/en.2004-0973","article-title":"Glia mediates the neuroprotective action of estradiol on beta-amyloid-induced neuronal death","volume":"145","author":"Sortino","year":"2004","journal-title":"Endocrinology"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0026-895X(25)08714-0","article-title":"Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons","volume":"49","author":"Prehn","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0006-8993(96)00458-1","article-title":"Transforming growth factors-beta protect primary rat hippocampal neuronal cultures from degeneration induced by beta-amyloid peptide","volume":"732","author":"Ren","year":"1996","journal-title":"Brain Res"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0169-328X(97)00108-3","article-title":"Transforming growth factor-beta protects human hNT cells from degeneration induced by beta-amyloid peptide: Involvement of the TGF-beta type II receptor","volume":"48","author":"Ren","year":"1997","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0169-328X(98)00217-4","article-title":"Transforming growth factor-beta inhibits apoptosis induced by beta-amyloid peptide fragment 25-35 in cultured neuronal cells","volume":"62","author":"Kim","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1124\/mol.62.1.65","article-title":"SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7","volume":"62","author":"Inman","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.nbd.2006.01.004","article-title":"TGFbeta1 regulates the inflammatory response during chronic neurodegeneration","volume":"22","author":"Boche","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1212\/01.wnl.0000338622.27876.0d","article-title":"Microglial activation and amyloid deposition in mild cognitive impairment: A PET study","volume":"72","author":"Okello","year":"2009","journal-title":"Neurology"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1749-6632.2008.03972.x","article-title":"The role of neuroimmunomodulation in Alzheimer's disease","volume":"1153","author":"Maccioni","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB76|cit76","first-page":"1389","article-title":"Phagocytosis and deposition of vascular \u03b2-amyloid in rat brains injected with Alzheimer \u03b2-amyloid","volume":"140","author":"Frautschy","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/jnen\/61.9.760","article-title":"Astrocytes are less efficient in the removal of apoptotic lymphocytes than microglia cells: Implications for the role of glial cells in the inflamed central nervous system","volume":"61","author":"Magnus","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1359-6101(99)00033-7","article-title":"Co-activation of TGF-\u03b2 and cytokine signaling pathways are required for neurotropic functions","volume":"11","author":"Unsicker","year":"2000","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/978-1-4615-0123-7_13","article-title":"TGF-betas and their roles in the regulation of neuron survival","volume":"513","author":"Unsicker","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.nbd.2006.10.005","article-title":"GDNF applied to the MPTP-lesioned nigrostriatal system requires TGF-beta for its neuroprotective action","volume":"25","author":"Schober","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0301-0082(00)00014-9","article-title":"Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease","volume":"63","author":"Murer","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s11064-005-6960-y","article-title":"The role of neurotrophins in brain aging: A perspective in honor of Regino Perez-Polo","volume":"30","author":"Cotman","year":"2005","journal-title":"Neurochem Res"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/jnr.1229","article-title":"Transforming growth factor-beta1 enhances expression of brain-derived neurotrophic factor and its receptor, TrkB, in neurons cultured from rat cerebral cortex","volume":"66","author":"Sometani","year":"2001","journal-title":"J Neurosci Res"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0197-0186(00)00084-X","article-title":"TGF-beta1 inhibits caspase-3 activation and neuronal apoptosis in rat hippocampal cultures","volume":"38","author":"Zhu","year":"2001","journal-title":"Neurochem Int"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1523\/JNEUROSCI.22-10-03898.2002","article-title":"Transforming growth factor-b1 increases bad phosphorylation and protects neurons against damage","volume":"22","author":"Zhu","year":"2002","journal-title":"J Neurosci"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.neuroscience.2003.10.037","article-title":"Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase\/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways","volume":"123","author":"Zhu","year":"2004","journal-title":"Neuroscience"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0968-0004(99)01523-6","article-title":"Eukaryotic DNA polymerases, a growing family","volume":"25","author":"H\u00fcbscher","year":"2004","journal-title":"Trends Biochem Sci"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1523\/JNEUROSCI.21-08-02661.2001","article-title":"DNA replication precedes neuronal cell death in Alzheimer's disease","volume":"21","author":"Yang","year":"2001","journal-title":"J Neurosci"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1038\/sj.onc.1207516","article-title":"To die or not to die: How does p53 decide?","volume":"23","author":"Slee","year":"2004","journal-title":"Oncogene"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"7533","DOI":"10.1523\/JNEUROSCI.16-23-07533.1996","article-title":"Amyloid beta peptide of Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons","volume":"16","author":"Paradis","year":"1996","journal-title":"J Neurosci"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1523\/JNEUROSCI.1381-04.2004","article-title":"Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain","volume":"24","author":"Caricasole","year":"2004","journal-title":"J Neurosci"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0959-437X(98)80068-3","article-title":"Beta-catenin: A key mediator of Wnt signaling","volume":"8","author":"Willert","year":"1998","journal-title":"Curr Opin Genet Dev"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.brainresrev.2004.07.018","article-title":"Signal transduction during amyloid-beta-peptide neurotoxicity: Role in Alzheimer disease","volume":"47","author":"Fuentealba","year":"2004","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0896-6273(02)00764-X","article-title":"Depolarization drives beta-catenin into neuronal spines promoting changes in synaptic structure and function","volume":"35","author":"Murase","year":"2002","journal-title":"Neuron"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/nn1132","article-title":"Beta-catenin is critical for dendritic morphogenesis","volume":"6","author":"Yu","year":"2003","journal-title":"Nat Neurosci"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/jnnp.73.3.261","article-title":"Genetic variability in the insulin signalling pathway may contribute to the risk of late onset Alzheimer's disease","volume":"73","author":"Liolitsa","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1111\/j.1460-9568.2007.05869.x","article-title":"Reduced insulin-induced phosphatidylinositol-3-kinase activation in peripheral blood mononuclear leucocytes from patients with Alzheimer's disease","volume":"26","author":"Castri","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm1239","article-title":"A phase I clinical trial of nerve growth factor gene therapy for Alzheimer disease","volume":"11","author":"Tuszynski","year":"2005","journal-title":"Nat Med"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nm.1912","article-title":"Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease","volume":"15","author":"Nagahara","year":"2009","journal-title":"Nat Med"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1568007023339490","article-title":"Small molecule Trk receptor agonists and other neurotrophic factor mimetics","volume":"1","author":"Pollack","year":"2002","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB101|cit101","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2174\/187152708783885174","article-title":"The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors","volume":"7","author":"Skaper","year":"2008","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB102|cit102","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/1567205053585756","article-title":"Small molecule tgf-beta mimetics as potential neuroprotective factors","volume":"2","author":"Zhang","year":"2005","journal-title":"Curr Alzheimer Res"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB103|cit103","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2165\/00023210-200418070-00001","article-title":"Impact of estrogen therapy on Alzheimer's disease: A fork in the road?","volume":"18","author":"Brinton","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB104|cit104","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1210\/en.2006-0495","article-title":"Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: Therapeutic implications","volume":"147","author":"Chen","year":"2006","journal-title":"Endocrinology"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB105|cit105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cytogfr.2007.04.005","article-title":"TGF-beta1: A novel target for cardiovascular pharmacology","volume":"18","author":"Redondo","year":"2007","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB106|cit106","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1001\/archneur.57.11.1586","article-title":"Anti-inflammatory drugs protect against Alzheimer disease at low doses","volume":"57","author":"Broe","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB107|cit107","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00228-003-0618-y","article-title":"Does aspirin protect against Alzheimer's dementia? A study in a Swedish population-based sample aged > or = 80 years","volume":"59","author":"Nilsson","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB108|cit108","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1212\/01.wnl.0000277657.95487.1c","article-title":"Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease","volume":"69","author":"Li","year":"2007","journal-title":"Neurology"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB109|cit109","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2174\/156720508785132316","article-title":"Reduced risk of incident AD with elective statin use in a clinical trial cohort","volume":"5","author":"Sparks","year":"2008","journal-title":"Curr Alzheimer Res"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB110|cit110","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1161\/01.CIR.0000045664.75269.A5","article-title":"Acetylsalicylic acid inhibits cell proliferation by involving transforming growth factor-beta","volume":"107","author":"Redondo","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB111|cit111","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nm0195-74","article-title":"The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis","volume":"1","author":"Grainger","year":"1995","journal-title":"Nat Med"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB112|cit112","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/S0735-1097(02)01857-0","article-title":"Increased transforming growth factor-beta(1) circulating levels and production in human monocytes after 3-hydroxy-3-methyl-glutarylcoenzyme a reductase inhibition with pravastatin","volume":"39","author":"Porreca","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB113|cit113","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cyto.2006.11.001","article-title":"Effects of atorvastatin and aspirin combined therapy on inflammatory responses in patients undergoing coronary artery bypass grafting","volume":"36","author":"Nakamura","year":"2006","journal-title":"Cytokine"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB114|cit114","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2165\/00023210-200216120-00004","article-title":"Glatiramer acetate: A review of its use in relapsing-remitting multiple sclerosis","volume":"16","author":"Simpson","year":"2002","journal-title":"CNS Drugs"},{"issue":"Suppl 2","key":"10.1111\/j.1755-5949.2009.00115.x-BIB115|cit115","doi-asserted-by":"crossref","first-page":"14593","DOI":"10.1073\/pnas.0404887101","article-title":"Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications","volume":"101","author":"Arnon","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB116|cit116","doi-asserted-by":"crossref","first-page":"19045","DOI":"10.1073\/pnas.0509438102","article-title":"The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice","volume":"102","author":"Aharoni","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB117|cit117","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1600-051X.2006.00935.x","article-title":"Enhanced susceptibility to periodontitis in an animal model of depression: Reversed by chronic treatment with the anti-depressant tianeptine","volume":"33","author":"Breivik","year":"2006","journal-title":"J Clin Periodontol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB118|cit118","doi-asserted-by":"crossref","DOI":"10.1155\/2007\/76396","article-title":"Pro- and anti-inflammatory cytokine balance in major depression: Effect of sertraline therapy","author":"Sutcigil","year":"2007","journal-title":"Clin Dev Immunol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB119|cit119","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1017\/S1461145707007729","article-title":"Venlafaxine exhibits an anti-inflammatory effect in an inflammatory co-culture model","volume":"11","author":"Vollmar","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB120|cit120","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.expneurol.2007.01.037","article-title":"Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice","volume":"205","author":"Nelson","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB121|cit121","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","article-title":"Depression and risk for Alzheimer disease: Systematic review, meta-analysis, and metaregression analysis","volume":"63","author":"Ownby","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB122|cit122","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/archneur.61.8.1290","article-title":"Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: A prospective cohort study","volume":"61","author":"Modrego","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB123|cit123","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jad.2005.07.008","article-title":"Th1, Th2, and Th3 cytokine alterations in major depression","volume":"88","author":"Myint","year":"2005","journal-title":"J Affect Disord"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB124|cit124","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.intimp.2006.03.015","article-title":"The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive Disorder","volume":"6","author":"Lee","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB125|cit125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jad.2008.11.020","article-title":"Antidepressants and dementia","volume":"117","author":"Kessing","year":"2009","journal-title":"J Affect Disord"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB126|cit126","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1254\/jphs.CRJ05009X","article-title":"Lithium: Potential therapeutics against acute brain injuries and chronic neurodegenerative diseases","volume":"99","author":"Wada","year":"2005","journal-title":"J Pharmacol Sci"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB127|cit127","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.mehy.2008.03.049","article-title":"Lithium may be useful in the prevention of Alzheimer's disease in individuals at risk of presenile familial Alzheimer's disease","volume":"71","author":"Yeh","year":"2008","journal-title":"Med Hypotheses"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB128|cit128","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1192\/bjp.bp.106.029868","article-title":"Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder","volume":"190","author":"Nunes","year":"2007","journal-title":"Br J Psychiatry"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB129|cit129","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.mcn.2007.10.017","article-title":"Lithium inhibits Smad 3\/4 transactivation via increased CREB activity induced by enhanced PKA and AKT signaling","volume":"37","author":"Liang","year":"2008","journal-title":"Mol Cell Neurosc"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB130|cit130","doi-asserted-by":"crossref","first-page":"9594","DOI":"10.1523\/JNEUROSCI.18-23-09594.1998","article-title":"Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta","volume":"18","author":"Bruno","year":"1998","journal-title":"J Neurosci"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB131|cit131","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1046\/j.1471-4159.2001.00435.x","article-title":"Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways","volume":"78","author":"D\u2019Onofrio","year":"2001","journal-title":"J Neurochem"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB132|cit132","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0026-895X(25)08600-6","article-title":"Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide","volume":"47","author":"Copani","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB133|cit133","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nm1632","article-title":"Activation of mGlu2\/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial","volume":"13","author":"Patil","year":"2007","journal-title":"Nat Med"},{"key":"10.1111\/j.1755-5949.2009.00115.x-BIB134|cit134","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.38330.470486.8F","article-title":"Atypical antipsychotic drugs and risk of ischaemic stroke: Population based retrospective cohort study","author":"Gill","year":"2005","journal-title":"BMJ"}],"container-title":["CNS Neuroscience &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1755-5949.2009.00115.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1755-5949.2009.00115.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T09:54:36Z","timestamp":1739440476000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1755-5949.2009.00115.x"}},"subtitle":["Neuroprotective Role of TGF-\u03b21 in AD"],"short-title":[],"issued":{"date-parts":[[2009,11,19]]},"references-count":134,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1755-5949.2009.00115.x","relation":{},"ISSN":["1755-5930"],"issn-type":[{"value":"1755-5930","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11,19]]}}}